Primary response by health organizations to mRNA vaccine study findings by end of 2025?
Guideline updates • 25%
Further studies commissioned • 25%
No significant action • 25%
Vaccine suspension or recall • 25%
Official statements from health organizations like WHO, CDC, or similar
Study of 99 Million Vaccinated Finds 610% Increased Myocarditis Risk and Other Adverse Events Post mRNA COVID-19 Vaccines
Jan 14, 2025, 03:43 PM
A large-scale study involving 99 million vaccinated individuals has confirmed an increased risk of adverse events following mRNA-based COVID-19 vaccinations, including a 610% increased risk of myocarditis. Additionally, a descriptive analysis of 241 individuals who self-reported a post-vaccination syndrome (PVS) after receiving the COVID-19 vaccine showed that the most common symptoms were exercise intolerance (71%), excessive fatigue (69%), numbness (63%), brain fog (63%), and neuropathy (63%). These individuals reported a median of 20 symptoms and tried a median of 20 treatments, indicating a significant health burden. The study also highlighted the detection of recombinant spike protein in the plasma of vaccinated individuals, suggesting systemic distribution of the vaccine's components. Furthermore, research has indicated that mRNA vaccines may impair innate immunity by suppressing type I interferon responses and could potentially increase the risk of infectious diseases and cancer due to disturbances in regulatory control of protein synthesis and cancer surveillance.
View original story
Undetermined • 25%
No issues found • 25%
Minor issues found • 25%
Significant issues found • 25%
Issue new safety guidelines • 25%
Other actions • 25%
No action taken • 25%
Conduct further studies • 25%
Some vaccines recommended for elimination • 25%
Comprehensive overhaul of vaccine policies • 25%
No changes recommended • 25%
Enhanced safety protocols recommended • 25%
Critical • 25%
No significant response • 25%
Supportive • 25%
Neutral • 25%
No significant change • 25%
Mixed responses • 25%
Increased trust • 25%
Decreased trust • 25%
No • 50%
Yes • 50%
No change • 25%
Increased studies • 25%
Revised guidelines • 25%
Other actions • 25%
Increased demand for transparency • 25%
Indifference • 25%
Increased trust in vaccines • 25%
Decreased trust in vaccines • 25%
Mixed • 25%
Unchanged • 25%
Mostly positive • 25%
Mostly negative • 25%
Decreased trust in mRNA vaccines • 25%
Increased trust in mRNA vaccines • 25%
Mixed opinions • 25%
Trust remains unchanged • 25%
Conduct further studies • 25%
No official response • 25%
Dismiss the findings • 25%
Issue new warnings • 25%
Oppose changes • 25%
No official stance • 25%
Support changes • 25%
Neutral stance • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Brain fog • 25%
Numbness • 25%
Exercise intolerance • 25%
Excessive fatigue • 25%